TL-32711

TL-32711
Item number Size Datasheet Manual SDS Delivery time Quantity Price
LKT-T4400.1 1 mg -

3 - 8 business days*

90.00€
LKT-T4400.5 5 mg -

3 - 8 business days*

256.00€
LKT-T4400.10 10 mg -

3 - 8 business days*

485.00€
 
TL-32711 is a Smac mimetic that is currently in clinical trials as a potential treatment for a... more
Product information "TL-32711"
TL-32711 is a Smac mimetic that is currently in clinical trials as a potential treatment for a variety of cancers. TL-32711 inhibits members of the inhibitor of apoptosis protein (IAP) family proteins, inducing degradation of cIAP1 and cIAP2. TL-32711 exhibits anticancer chemotherapeutic activity, inhibiting NF-kappaB activation and tumor growth in animal models. In acute myelogenous leukemia (AML) cells, this compound induces caspase 8-mediated apoptosis.
Keywords: Birinapant
Supplier: LKT Laboratories
Supplier-Nr: T4400

Properties

Application: Antineoplastic, Smac mimetic
MW: 806.94 D
Purity: >98%
Format: Solid

Database Information

CAS : 1260251-31-7| Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "TL-32711"
Write a review
or to review a product.
Viewed